Characterization of the spherical intermediates and fibril formation of hCT in HEPES solution using solid-state 13C-NMR and transmission electron microscopy.

Human calcitonin (hCT) is a 32-amino acid peptide hormone that contains an intrachain disulfide bridge between Cys1 and Cys7 and a proline amide at the C-terminus. hCT tends to associate to form a fibril precipitate of the same type as amyloid fibrils, and hence has been studied as a model of amyloid fibril formation. The fibrillation process in N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid (HEPES) solution was examined using transmission electron microscopy. The rate of hCT fibrillation in HEPES solution was much lower than in phosphate buffer and acetic acid solution. Spherical intermediate aggregates (nuclei) were observed during the early stage of fibril formation. Short proto-fibrils appeared on the surface of the spherical intermediates. Subsequently, the spherical intermediates transformed directly into long proto-fibrils, which then elongated into mature hCT fibrils. The fibrillation process was also examined using solid-state (13)C-NMR spectroscopy, which indicated that the fibril structure was a β-sheet in the central region and a mixture of random coils and β-sheets at the C-terminus. The kinetics of fibril formation was examined in terms of a two-step autocatalytic reaction mechanism. The first-step nucleation rate (k1) was lower in HEPES solution than in phosphate buffer and acetic acid solution because the half-life of the intermediates is significantly longer in HEPES solution. In contrast, the second-step fibril elongation rate (k2) was similar in HEPES solution and acidic solutions. Specific interaction of HEPES molecules with hCT may stabilize the spherical intermediates and consequently inhibit the fibril elongation process of hCT.

[1]  J. Agar,et al.  Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth. , 2008, Biochemistry.

[2]  I. Ando,et al.  High-Resolution Solid-State NMR Studies of Synthetic and Biological Macromolecules , 1989 .

[3]  A. Naito,et al.  Conformational transitions and fibrillation mechanism of human calcitonin as studied by high‐resolution solid‐state 13C NMR , 2000, Protein science : a publication of the Protein Society.

[4]  Hazime Saitô,et al.  Conformation‐dependent 13C chemical shifts: A new means of conformational characterization as obtained by high‐resolution solid‐state 13C NMR , 1986 .

[5]  Y. Ishii,et al.  Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid , 2007, Nature Structural &Molecular Biology.

[6]  A. Naito,et al.  Structural diversity of amyloid fibril formed in human calcitonin as revealed by site‐directed 13C solid‐state NMR spectroscopy , 2004, Magnetic resonance in chemistry : MRC.

[7]  E. Gazit,et al.  The early stages of amyloid formation: Biophysical and structural characterization of human calcitonin pre-fibrillar assemblies , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[8]  K. Imahori,et al.  Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains* , 2009, The Journal of Biological Chemistry.

[9]  V. Saudek,et al.  Solution structure of salmon calcitonin , 1991, Biopolymers.

[10]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  I. Macintyre,et al.  FURTHER EVIDENCE FOR CALCITONIN. A RAPID-ACTING HORMONE WHICH LOWERS PLASMA-CALCIUM. , 1963, Lancet.

[12]  Dominic M. Walsh,et al.  Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.

[13]  A. Pastore,et al.  Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations. , 1991, Biochemistry.

[14]  D. Teplow,et al.  Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[15]  K. Kanaori,et al.  Study of human calcitonin fibrillation by proton nuclear magnetic resonance spectroscopy. , 1995, Biochemistry.

[16]  A. Naito,et al.  Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides. , 2007, Biochimica et biophysica acta.

[17]  A. Paquet Introduction of 9-fluorenylmethyloxycarbonyl, trichloroethoxycarbonyl, and benzyloxycarbonyl amine protecting groups into O-unprotected hydroxyamino acids using succinimidyl carbonates , 1982 .

[18]  H. Heath,et al.  Calcitonin: physiology and pathophysiology. , 1981, The New England journal of medicine.

[19]  A. Drake,et al.  The structure and mechanism of formation of human calcitonin fibrils. , 1993, The Journal of biological chemistry.

[20]  R. Matas,et al.  War wounds of the lungs. , 1947, Lancet.

[21]  M. Fändrich,et al.  Phosphate and HEPES buffers potently affect the fibrillation and oligomerization mechanism of Alzheimer's Aβ peptide. , 2011, Biochemical and biophysical research communications.

[22]  Isao Ando,et al.  Chemical shift tensor - the heart of NMR: Insights into biological aspects of proteins. , 2010, Progress in nuclear magnetic resonance spectroscopy.

[23]  Kazuki Sato,et al.  Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Copp,et al.  Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium. , 1962, Endocrinology.

[25]  Y. Ishii,et al.  Capturing intermediate structures of Alzheimer's β-amyloid, Aβ(1-40), by solid-state NMR spectroscopy , 2005 .

[26]  A. Griffiths,et al.  Pathological features of multiple endocrine neoplasia type IIb in childhood. , 1990, Pediatric pathology.

[27]  A. Naito,et al.  Effect of Electrostatic Interaction on Fibril Formation of Human Calcitonin as Studied by High Resolution Solid State 13C NMR* , 2003, The Journal of Biological Chemistry.

[28]  U Aebi,et al.  Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. , 1995, Journal of structural biology.

[29]  D. Gorenstein,et al.  Two-dimensional NMR and structure determination of salmon calcitonin in methanol. , 1991, Biochemistry.

[30]  P. Sieber,et al.  [Human calcitonin. VI. Synthesis of calcitonin M]. , 1970, Helvetica chimica acta.

[31]  A. Naito,et al.  NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. , 2012, Journal of molecular biology.

[32]  Shinichiro Nakamura,et al.  Two Distinct Amyloid β-Protein (Aβ) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses* , 2011, The Journal of Biological Chemistry.

[33]  N. Berger,et al.  Calcitonin-like immunoreactivity of amyloid fibrils in medullary thyroid carcinomas , 1988, Virchows Archiv A.

[34]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[35]  A. Naito,et al.  Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation. , 2013, Physical chemistry chemical physics : PCCP.

[36]  D. Kern,et al.  The cis/trans interconversion of the calcium regulating hormone calcitonin is catalyzed by cyclophilin , 1993, FEBS letters.